Article Information
History
- March 9, 2023.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC 4.0 International license.
Author Information
- Matthew M. Grabowski+,*,1,2,3,4,
- Dionysios C. Watson*,1,2,4,5,
- Kunho Chung1,
- Juyeun Lee1,
- Defne Bayik1,
- Adam Lauko1,4,7,
- Tyler Alban1,
- Jan Joseph Melenhorst1,
- Timothy Chan1,2,
- Justin D. Lathia#,1,2,3,4,
- Manmeet S. Ahluwalia+,#,6 and
- Alireza M. Mohammadi+,#,1,2,3,4
- 1Cleveland Clinic Lerner Research Institute, Cleveland, OH, USA
- 2Case Comprehensive Cancer Center, Cleveland, OH, USA
- 3Rose Ella Burkhardt Brain Tumor and Neuro-Oncology Center, Department of Neurosurgery, Cleveland, OH, USA
- 4Case Western Reserve University, Cleveland, OH, USA
- 5University Hospitals Cleveland Medical Center, Cleveland, OH, USA
- 6Miami Cancer Institute, Baptist Health South Florida, Miami, FL, USA
- 7Medical Scientist Training Program, Case Western Reserve University School of Medicine, Cleveland, Ohio, USA
- ↵+Corresponding authors Manmeet S. Ahluwalia, 8900 N Kendall Drive Miami FL 33176, email: ManmeetA{at}baptisthealth.net, Alireza M. Mohammadi, Cleveland Clinic CA-51 9500 Euclid Ave., Cleveland, OH 44195, Office: (216) 445-4290, fax: (216) 444-0924, email: mohamma3{at}ccf.org
Posted March 09, 2023.
Spatial immunosampling of MRI-defined glioblastoma regions reveals immunologic fingerprint of non-contrast enhancing, infiltrative tumor margins
